US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Horizon Kinetics Blockchain Development ETF

31.99

-0.0573-0.18%

Post-market: 32.080.0863+0.27%16:10 EDT

Volume:634

Turnover:20.34K

Market Cap:23.20M

PE:- -

High:32.08

Open:32.08

Low:31.99

Close:32.05

52wk High:36.27

52wk Low:29.01

Shares:725.00K

Float Shares:725.00K

Volume Ratio:0.36

T/O Rate:0.09%

Dividend:0.76

Dividend Rate:2.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

ChemoMetec Completes DKK 100 Million Share Buyback Program, Repurchases 239,950 Shares

Crispr Therapeutics Presents Phase 1 Zugo-Cel Data in Refractory Systemic Sclerosis at ACR Convergence 2026

Intercontinental Exchange Price Target Raised to $195.00/Share from $190.00 by Piper Sandler

SeaStar Medical to Present SAVE Registry Data on SCD-PED Outcomes in Pediatric Sepsis-Associated AKI at ASN Kidney Week 2026

InterContinental Exchange, Inc. : Bofa Global Research Raises Price Objective to $236 from $232

THOMSON REUTERS

YYForce Deploys Hospitality Service Robot at Aloft Langkawi Pantai Tengah in Malaysia

Climb Bio to Present Preliminary Phase 2 PrisMN Trial Data for Budoprutug in Primary Membranous Nephropathy at ASN Kidney Week 2026

Matador Technologies Calls Shareholder Meeting

Newcleo Names Ex-TVA Chief Jeffrey Lyash Board Chairman

Vera Therapeutics Says Origin 3 Final Efficacy Data for Trutakna in IgA Nephropathy is Set for Late-Breaking ASN Kidney Week 2026 Talk

Decent Holding Prices Private Placement of Unregistered Warrants for 822,828 Shares at $1.50 Each

Christian Dior Reports 180,507,516 Issued Shares as of Sept. 30, 2026

Artiva Biotherapeutics Posts Updated Phase 2a AlloNK Plus Rituximab Data in Refractory Rheumatoid Arthritis at ACR 2026

iTonic Holdings Announces 16-for-1 Share Consolidation Effective Oct. 6

Immuneering Plans Phase 2 Trial of Atebimetinib Plus PD-1 Blockade in Lung Cancer Patients

ATA Creativity Global Gets NASDAQ Notice After ADS Bid Price Stays Below $1

ProKidney Posts Pooled Phase 2 Data Showing Rilparencel Stabilizes Kidney Function in Advanced CKD with Diabetes

Cuprina to Buy Singapore Healthcare Group East Coast Podiatry and Orchard Clinic for S$4 Million

Evaxion to Present New Phase 2 Immune Data for EVX-01 Melanoma Vaccine at SITC 2026

Candel Therapeutics to Present NSCLC Aglatimagene Besadenovec Study Data at SITC 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BCDF/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BCDF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDF\",,,,,undefined,":{"symbol":"BCDF","market":"US","secType":"STK","nameCN":"Horizon Kinetics Blockchain Development ETF","latestPrice":31.9937,"timestamp":1790971200000,"preClose":32.051,"halted":0,"volume":634,"hourTrading":{"tag":"盘后","latestPrice":32.08,"preClose":31.9937,"latestTime":"16:10 EDT","volume":6,"amount":191.9622,"timestamp":1790971804464,"change":0.0863,"changeRate":0.002697,"amplitude":0},"delay":0,"changeRate":-0.001787775732426491,"floatShares":725000,"shares":725000,"eps":0,"marketStatus":"Market Closed","change":-0.0573,"latestTime":"10-02 16:00:00 EDT","open":32.08,"high":32.08,"low":31.9937,"amount":20343,"amplitude":0.002693,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":32.051,"sharesOutstanding":675000,"nav":32.17,"aum":23323250,"dividendRate":0.023836,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":32.08,"preClose":31.9937,"latestTime":"16:10 EDT","volume":6,"amount":191.9622,"timestamp":1790971804464,"change":0.0863,"changeRate":0.002697,"amplitude":0},"volumeRatio":0.3561797412637326},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDF\",,,,,undefined,":{"symbol":"BCDF","floatShares":725000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3561797412637326,"shares":725000,"dividePrice":0.7626,"high":32.08,"amplitude":0.002693,"preClose":32.051,"low":31.9937,"week52Low":29.01,"pbRate":"--","week52High":36.27,"institutionHeld":0,"latestPrice":31.9937,"eps":0,"divideRate":0.023836,"volume":634,"delay":0,"ttmEps":0,"open":32.08,"prevYearClose":30.2172,"prevWeekClose":32.4777,"prevMonthClose":32.0003,"prevQuarterClose":32.0003,"fiveDayClose":32.4777,"twentyDayClose":34.0114,"sixtyDayClose":31.0085},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCDF\",params:#limit:5,,,undefined,":[{"date":"2024-12-24","symbol":"BCDF","amount":0.45302,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"Horizon Kinetics Blockchain Development ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"BCDF","amount":0.169967,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"},{"market":"US","date":"2022-12-28","symbol":"BCDF","amount":0.05244,"defaultRemindTime":1672237800000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2022-09-28","symbol":"BCDF","amount":0.0219,"defaultRemindTime":1664371800000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2022-09-30","payableDate":"2022-09-29","currency":"USD","type":"dividend","dateTimestamp":1664337600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCDF\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-28","recordDate":"2022-09-29","paymentDate":"2022-09-30","value":0.0219,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.05244,"currency":"USD"},{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":0.169967,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.45302,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCDF\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCDF\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672287710","title":"ChemoMetec Completes DKK 100 Million Share Buyback Program, Repurchases 239,950 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2672287710","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672287710?lang=en_us&edition=fundamental","pubTime":"2026-10-02 22:52","pubTimestamp":1790952757,"startTime":"0","endTime":"0","summary":"ChemoMetec completes DKK 100 million share buyback program, repurchases 239,950 sharesChemoMetec completed a share buyback launched on May 15, 2026, targeting up to 500,000 shares for up to DKK 100 mi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7bRn7B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3C00.GBP","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","NDAQ","SG9999014021.USD","BK4112","IE00BQXX3F31.USD","BK4585","BK4588","SG9999014039.USD","BCDF","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014013.SGD","IE00BKPKM429.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BQXX3D17.EUR","IE00BGHQF748.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672170057","title":"Crispr Therapeutics Presents Phase 1 Zugo-Cel Data in Refractory Systemic Sclerosis at ACR Convergence 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672170057","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672170057?lang=en_us&edition=fundamental","pubTime":"2026-10-02 22:16","pubTimestamp":1790950565,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics presents Phase 1 zugo-cel data in refractory systemic sclerosis at ACR Convergence 2026CRISPR Therapeutics flagged Phase 1 clinical data for its CD19-targeting allogeneic CAR-T can","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDLbmv3d0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","ARKG","SG9999014039.USD","BK4112","IE00BKPKM429.USD","LU1861558580.USD","SG9999014021.USD","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","BCDF","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00BQXX3F31.USD","LU1861559042.SGD","IE00BQXX3C00.GBP","CRSP","BK4139","BK4611","LU0314104364.USD","BK4585","IE00BN0W2T93.GBP","BK4556","IE00BQXX3D17.EUR","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4588","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672971724","title":"Intercontinental Exchange Price Target Raised to $195.00/Share from $190.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2672971724","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672971724?lang=en_us&edition=fundamental","pubTime":"2026-10-02 22:04","pubTimestamp":1790949840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ICE/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","LU0661504455.SGD","LU0011850046.USD","SG9999004303.SGD","SGXZ23171101.USD","LU0154245673.USD","LU1974910355.USD","BCDF","LU0477156953.USD","IE00BQXX3F31.USD","BK4588","LU0689626769.HKD","LU0154245756.USD","LU1506573853.SGD","BK4112","LU0130102774.USD","LU0072461881.USD","LU0256863902.USD","LU0124676726.USD","LU2023250504.SGD","GB00BDT5M118.USD","LU2237957811.SGD","LU1917777945.USD","LU0256863811.USD","LU0949170772.SGD","LU0130517989.USD","BK4585","LU0971096721.USD","LU1153585028.USD","LU1201861249.SGD","LU0390134368.USD","LU0738911758.USD","LU0417517546.SGD","LU0314106906.USD","LU0980610538.SGD","LU1363072403.SGD","LU0154236417.USD","IE00BQXX3D17.EUR","LU0648001328.SGD","ICE","IE00BQXX3C00.GBP","LU2237957902.USD","LU2106854487.HKD","LU2023250843.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672717555","title":"SeaStar Medical to Present SAVE Registry Data on SCD-PED Outcomes in Pediatric Sepsis-Associated AKI at ASN Kidney Week 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672717555","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672717555?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:43","pubTimestamp":1790948595,"startTime":"0","endTime":"0","summary":"SeaStar Medical to present SAVE registry data on SCD-PED outcomes in pediatric sepsis-associated AKI at ASN Kidney Week 2026SeaStar Medical flagged new post-approval registry results for its QUELIMMUN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL1JxxXH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","BK4082","SG9999014039.USD","IE00BQXX3D17.EUR","SG9999014021.USD","IE00BKPKM429.USD","LU2095319765.USD","IE00BQXX3C00.GBP","ICU","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","BK4112","BCDF","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","BK4588","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD","LU0314104364.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672717589","title":"InterContinental Exchange, Inc. : Bofa Global Research Raises Price Objective to $236 from $232","url":"https://stock-news.laohu8.com/highlight/detail?id=2672717589","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672717589?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:42","pubTimestamp":1790948528,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O1BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4112","LU2023250843.SGD","ICE","LU0072461881.USD","LU1506573853.SGD","IE00BQXX3D17.EUR","LU2023250504.SGD","LU1201861249.SGD","LU0689626769.HKD","LU2237957902.USD","LU0256863811.USD","BK4585","LU0154245756.USD","LU0390134368.USD","LU0648001328.SGD","LU1974910355.USD","LU2237957811.SGD","LU0130517989.USD","LU0314106906.USD","LU0738911758.USD","LU0162691827.USD","LU0011850046.USD","LU0256863902.USD","IE00BQXX3F31.USD","LU0949170772.SGD","LU1153585028.USD","SG9999004303.SGD","LU0477156953.USD","LU0154236417.USD","LU0124676726.USD","IE00BQXX3C00.GBP","LU0980610538.SGD","LU0154245673.USD","BK4588","LU0661504455.SGD","LU0971096721.USD","LU1917777945.USD","LU2106854487.HKD","LU1363072403.SGD","LU0417517546.SGD","BCDF","SGXZ23171101.USD","LU0130102774.USD","GB00BDT5M118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672717350","title":"YYForce Deploys Hospitality Service Robot at Aloft Langkawi Pantai Tengah in Malaysia","url":"https://stock-news.laohu8.com/highlight/detail?id=2672717350","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672717350?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:39","pubTimestamp":1790948363,"startTime":"0","endTime":"0","summary":"YYForce deploys hospitality service robot at Aloft Langkawi Pantai Tengah in MalaysiaYYForce deployed a YY Circle Malaysia hospitality service robot at Aloft by Marriott Langkawi Pantai Tengah in Lang","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDLvfwp8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B95QR487.USD","BCDF","IE00B64PRP62.GBP","YFOR","SG9999014021.USD","BK4112","IE00BQXX3D17.EUR","SG9999014039.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2404859667.USD","SG9999014005.SGD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","GB00B4QBRK32.GBP","LU2210150020.SGD","IE00BN0W2T93.GBP","BK4120","IE00B0T0GQ85.USD","SG9999014013.SGD","NDAQ","BK4585","LU0690374615.EUR","LU2095319765.USD","IE00B1G9WX41.USD","BK4588","LU1718418525.SGD","BK4142","IE00B45NX917.SGD","IE00BD0PCF45.HKD","IE00BN0W2W23.USD","LU0314104364.USD","LU2404859741.USD","LU0690374961.EUR","IE00BN0W2V16.EUR","GB00B4LPDJ14.GBP","MAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712067","title":"Climb Bio to Present Preliminary Phase 2 PrisMN Trial Data for Budoprutug in Primary Membranous Nephropathy at ASN Kidney Week 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712067","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712067?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:30","pubTimestamp":1790947822,"startTime":"0","endTime":"0","summary":"Climb Bio to present preliminary Phase 2 PrisMN trial data for budoprutug in primary membranous nephropathy at ASN Kidney Week 2026Climb Bio flagged new clinical updates for CLYM116 and budoprutug ahe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL3hhf87:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BCDF","BK4585","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014005.SGD","SG9999014021.USD","BK4539","BK4588","LU2210150020.SGD","BK4112","IE00BQXX3C00.GBP","NDAQ","LU0314104364.USD","SG9999014013.SGD","CLYM","IE00BQXX3F31.USD","SG9999014039.USD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672871206","title":"Matador Technologies Calls Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2672871206","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672871206?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:30","pubTimestamp":1790947813,"startTime":"0","endTime":"0","summary":"Matador Technologies calls shareholder meetingMatador Technologies will hold its annual general and special meeting in Toronto on Oct. 14, 2026.Shareholders will vote on a proposed amendment to create","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL8QlsfF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","LU2210149790.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","SG9999014021.USD","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","LU2095319765.USD","NDAQ","LU0314104364.USD","BK4112","BK4585","IE00BKPKM429.USD","BCDF","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","SG9999014039.USD","IE00B64PRP62.GBP","SG9999014005.SGD","BK4588","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672871279","title":"Newcleo Names Ex-TVA Chief Jeffrey Lyash Board Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2672871279","media":"Reuters","labels":["executive","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672871279?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:27","pubTimestamp":1790947638,"startTime":"0","endTime":"0","summary":"Newcleo names ex-TVA chief Jeffrey Lyash board chairmanNewcleo named former Tennessee Valley Authority CEO Jeffrey Lyash as board chairman, bringing 40 years of power-sector engineering and operations","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL1DxWd1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","NWCL","LU2210149790.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","SG9999014021.USD","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","LU2095319765.USD","NDAQ","LU0314104364.USD","BK4112","BK4585","IE00BKPKM429.USD","BCDF","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","SG9999014039.USD","IE00B64PRP62.GBP","SG9999014005.SGD","BK4588","IE00BQXX3F31.USD","TVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712271","title":"Vera Therapeutics Says Origin 3 Final Efficacy Data for Trutakna in IgA Nephropathy is Set for Late-Breaking ASN Kidney Week 2026 Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712271","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712271?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:24","pubTimestamp":1790947481,"startTime":"0","endTime":"0","summary":"Vera Therapeutics says ORIGIN 3 final efficacy data for TRUTAKNA in IgA nephropathy is set for late-breaking ASN Kidney Week 2026 talkVera Therapeutics flagged final efficacy results from the Phase 3 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7dZbDS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2210150020.SGD","LU2095319765.USD","IE00BN0W2T93.GBP","NDAQ","SG9999014021.USD","BK4588","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","VERA","LU2324357040.USD","IE00BN0W2W23.USD","LU2210149790.SGD","IE00BN0W2V16.EUR","BK4539","BK4112","IE00BGHQF748.EUR","SG9999014005.SGD","BK4139","BCDF","IE00BKPKM429.USD","IE00BQXX3C00.GBP","SG9999014039.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712402","title":"Decent Holding Prices Private Placement of Unregistered Warrants for 822,828 Shares at $1.50 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712402","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712402?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:20","pubTimestamp":1790947219,"startTime":"0","endTime":"0","summary":"Decent Holding prices private placement of unregistered warrants for 822,828 shares at $1.50 eachDecent Holding priced a concurrent private placement of unregistered warrants to buy 822,828 Class A or","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL40K45F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4120","SG9999014039.USD","LU2210149790.SGD","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","BK4112","IE00B3QW5Z07.USD","BCDF","IE00B64PRP62.GBP","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","NDAQ","IE00BN0W2T93.GBP","BK4588","BK4585","LU0314104364.USD","SG9999014013.SGD","LU2210150020.SGD","IE00BKPKM429.USD","DXST","SG9999014005.SGD","IE00BQXX3C00.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672671291","title":"Christian Dior Reports 180,507,516 Issued Shares as of Sept. 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672671291","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672671291?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:14","pubTimestamp":1790946898,"startTime":"0","endTime":"0","summary":"Christian Dior reports 180,507,516 issued shares as of Sept. 30, 2026Christian Dior reported 180,507,516 issued shares as of Sept. 30, 2026.Gross voting rights totaled 356,941,538.Net voting rights st","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL1zXW7S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2095319765.USD","SG9999014039.USD","IE00BQXX3D17.EUR","SG9999014021.USD","IE00BQXX3F31.USD","BK4585","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","BK4112","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BQXX3C00.GBP","SG9999014013.SGD","BK4588","LU0314104364.USD","BCDF","SG9999014005.SGD","IE00BN0W2V16.EUR","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672125177","title":"Artiva Biotherapeutics Posts Updated Phase 2a AlloNK Plus Rituximab Data in Refractory Rheumatoid Arthritis at ACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672125177","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672125177?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:05","pubTimestamp":1790946328,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics posts updated Phase 2a AlloNK plus rituximab data in refractory rheumatoid arthritis at ACR 2026Artiva Biotherapeutics flagged updated Phase 2a basket-trial results for AlloNK w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL5PDSjG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","BK4139","LU2210149790.SGD","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","IE00BN0W2V16.EUR","BCDF","IE00BGHQF748.EUR","SG9999014021.USD","IE00BN0W2T93.GBP","NDAQ","SG9999014039.USD","IE00BN0W2W23.USD","LU2210150020.SGD","BK4588","BK4112","LU2095319765.USD","ARTV","IE00BKPKM429.USD","LU0314104364.USD","IE00B64PRP62.GBP","SG9999014013.SGD","BK4585","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712342","title":"iTonic Holdings Announces 16-for-1 Share Consolidation Effective Oct. 6","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712342","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712342?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:01","pubTimestamp":1790946114,"startTime":"0","endTime":"0","summary":"iTonic Holdings announces 16-for-1 share consolidation effective Oct. 6iTonic will execute a 16-for-1 share consolidation effective 12:01 a.m. ET on Oct. 6, 2026.Nasdaq trading is expected to begin on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL9qRmPl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014005.SGD","BK4588","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014039.USD","IE00BKPKM429.USD","BK4585","LU2095319765.USD","BK4112","IE00B64PRP62.GBP","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","NDAQ","IE00BQXX3F31.USD","LU2210149790.SGD","ITOC","BK4167","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672171234","title":"Immuneering Plans Phase 2 Trial of Atebimetinib Plus PD-1 Blockade in Lung Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2672171234","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672171234?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:01","pubTimestamp":1790946113,"startTime":"0","endTime":"0","summary":"Immuneering plans Phase 2 trial of atebimetinib plus PD-1 blockade in lung cancer patientsImmuneering flagged preclinical results showing atebimetinib can strengthen PD-1 checkpoint blockade in RAS-mu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL50ZKvy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014039.USD","BK4563","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4139","LU0314104364.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","SG9999014021.USD","NDAQ","IE00BN0W2V16.EUR","LU2210149790.SGD","SG9999014005.SGD","BK4539","BK4588","LU2095319765.USD","IE00BQXX3F31.USD","BCDF","BK4585","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IMRX","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712312","title":"ATA Creativity Global Gets NASDAQ Notice After ADS Bid Price Stays Below $1","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712312","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712312?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:01","pubTimestamp":1790946089,"startTime":"0","endTime":"0","summary":"ATA Creativity Global gets Nasdaq notice after ADS bid price stays below $1Nasdaq issued a bid-price deficiency notice to ATA Creativity Global after its ADS bid stayed below $1.00 for 31 straight bus","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL8msm60:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BKPKM429.USD","SG9999014039.USD","AACG","LU0314104364.USD","IE00BN0W2W23.USD","IE00BQXX3F31.USD","LU2095319765.USD","LU2210149790.SGD","IE00BQXX3C00.GBP","SG9999014021.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4204","BCDF","BK4585","SG9999014005.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","NDAQ","BK4112","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712346","title":"ProKidney Posts Pooled Phase 2 Data Showing Rilparencel Stabilizes Kidney Function in Advanced CKD with Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712346","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712346?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:01","pubTimestamp":1790946087,"startTime":"0","endTime":"0","summary":"ProKidney posts pooled Phase 2 data showing rilparencel stabilizes kidney function in advanced CKD with diabetesProKidney flagged a new pooled Phase 2 analysis in advanced CKD with type 2 diabetes, wi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7TJRHh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4112","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","SG9999014005.SGD","IE00B64PRP62.GBP","BK4588","LU2095319765.USD","SG9999014039.USD","SG9999014021.USD","LU2210150020.SGD","BK4139","BCDF","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","LU0314104364.USD","LU2210149790.SGD","PROK","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BKPKM429.USD","NDAQ","IE00BQXX3F31.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712344","title":"Cuprina to Buy Singapore Healthcare Group East Coast Podiatry and Orchard Clinic for S$4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712344","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712344?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:01","pubTimestamp":1790946067,"startTime":"0","endTime":"0","summary":"Cuprina to buy Singapore healthcare group East Coast Podiatry and Orchard Clinic for S$4 millionCuprina entered SPAs to buy 100% of Singapore’s East Coast Podiatry and Orchard Clinic, totaling seven c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7M7xqN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BQXX3C00.GBP","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BQXX3F31.USD","BK4585","IE00B64PRP62.GBP","SG9999014005.SGD","LU2210149790.SGD","NDAQ","BK4112","BK4198","LU0314104364.USD","IE00BKPKM429.USD","BK4588","CUPR","IE00BGHQF748.EUR","SG9999014039.USD","IE00BN0W2V16.EUR","SG9999014021.USD","BCDF","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672123457","title":"Evaxion to Present New Phase 2 Immune Data for EVX-01 Melanoma Vaccine at SITC 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672123457","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672123457?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:01","pubTimestamp":1790946062,"startTime":"0","endTime":"0","summary":"Evaxion to present new phase 2 immune data for EVX-01 melanoma vaccine at SITC 2026Evaxion flagged new immune data from its phase 2 EVX-01 personalized cancer vaccine study in advanced melanoma.Result","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL1vWkZ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","LU2210149790.SGD","BK4139","IE00BQXX3C00.GBP","BK4585","SG9999014013.SGD","IE00BKPKM429.USD","LU0314104364.USD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4588","EVAX","BCDF","NDAQ","IE00BN0W2T93.GBP","SG9999014005.SGD","IE00BQXX3D17.EUR","SG9999014039.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BQXX3F31.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712822","title":"Candel Therapeutics to Present NSCLC Aglatimagene Besadenovec Study Data at SITC 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712822","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672712822?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:00","pubTimestamp":1790946058,"startTime":"0","endTime":"0","summary":"Candel Therapeutics to present NSCLC aglatimagene besadenovec study data at SITC 2026Candel Therapeutics set two poster presentations at SITC’s 41st Annual Meeting, November 4-8, 2026 in Phoenix.Resul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDLfkxys:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4139","IE00BQXX3F31.USD","SG9999014039.USD","SG9999014021.USD","IE00BQXX3D17.EUR","CADL","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BCDF","BK4539","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014005.SGD","BK4588","LU2210150020.SGD","IE00BQXX3C00.GBP","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","BK4585","NDAQ","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":81,"pageCount":4,"totalSize":1606,"code":"91000000","status":"200"}]}}